Online edition of India's National Newspaper
Thursday, Dec 19, 2002

About Us
Contact Us
Sci Tech Published on Thursdays

Features: Magazine | Literary Review | Life | Metro Plus | Open Page | Education | Book Review | Business | SciTech | Entertainment | Young World | Quest | Folio |

Sci Tech

Printer Friendly Page Send this Article to a Friend

Super computing and drug discovery

ONGOING PHASE III trials conducted by Bio Numerik, Texas (a pharmaceutical firm involved in rigorous cancer research) is experimenting with administration of higher dosage of chemotherapy without the side effects.

Another research project at the Institute of System Biology, Alaska has scientists working on Post Genomic research, to study the dynamics of cell and its working.

Both the drug design and the cell research projects are being conducted with assistance of Super computers.

If the Bio Numerik project proceeds to the Phase IV trials (tests on human beings), this would be the first time that a drug has been commercially developed using super computing tools, revealed Cray Inc.'s Chief Scientist Burton J.Smith to The Hindu. .

Also, if Bio Numerik were to use the latest Cray XI Super Computer, then drug discovery (phase III stage) would just take two weeks, he said.

"Super computers are allowing us to start on this process. In the case of drug discovery, the cycle time is compressed and productivity increased through super computing tools. Cray enables rational drug design through computational tools,'' explained Dr.Smith.

Besides traditional areas the super computers are increasingly being used by medical research including molecular simulation, genomics and proteomics and bio-informatics.

Preeti Mishra

in Bangalore

Printer friendly page  
Send this article to Friends by E-Mail

Sci Tech

Features: Magazine | Literary Review | Life | Metro Plus | Open Page | Education | Book Review | Business | SciTech | Entertainment | Young World | Quest | Folio |



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | Home |

Comments to : thehindu@vsnl.com   Copyright © 2002, The Hindu
Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu